ES2252427T3 - Procedimiento para la deteccion de moleculas de acido nucleico. - Google Patents
Procedimiento para la deteccion de moleculas de acido nucleico.Info
- Publication number
- ES2252427T3 ES2252427T3 ES02704467T ES02704467T ES2252427T3 ES 2252427 T3 ES2252427 T3 ES 2252427T3 ES 02704467 T ES02704467 T ES 02704467T ES 02704467 T ES02704467 T ES 02704467T ES 2252427 T3 ES2252427 T3 ES 2252427T3
- Authority
- ES
- Spain
- Prior art keywords
- baselineskip
- probes
- hybridization
- microarray
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 62
- 108020004707 nucleic acids Proteins 0.000 title claims abstract description 57
- 150000007523 nucleic acids Chemical class 0.000 title claims abstract description 57
- 102000039446 nucleic acids Human genes 0.000 title claims abstract description 57
- 238000001514 detection method Methods 0.000 title claims abstract description 38
- 239000000523 sample Substances 0.000 claims abstract description 118
- 238000009396 hybridization Methods 0.000 claims abstract description 97
- 238000002493 microarray Methods 0.000 claims abstract description 54
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 38
- 238000006243 chemical reaction Methods 0.000 claims abstract description 27
- 230000003115 biocidal effect Effects 0.000 claims abstract description 22
- 230000008018 melting Effects 0.000 claims abstract description 22
- 238000002844 melting Methods 0.000 claims abstract description 22
- 238000007403 mPCR Methods 0.000 claims abstract description 17
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 18
- 230000003321 amplification Effects 0.000 claims description 14
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 14
- 229960002685 biotin Drugs 0.000 claims description 12
- 239000011616 biotin Substances 0.000 claims description 12
- 239000011521 glass Substances 0.000 claims description 11
- 239000002773 nucleotide Substances 0.000 claims description 10
- 125000003729 nucleotide group Chemical group 0.000 claims description 10
- 235000020958 biotin Nutrition 0.000 claims description 9
- 238000000746 purification Methods 0.000 claims description 9
- 238000000926 separation method Methods 0.000 claims description 9
- 229940126575 aminoglycoside Drugs 0.000 claims description 7
- 101150064107 fosB gene Proteins 0.000 claims description 7
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 6
- 101000735344 Lymantria dispar Pheromone-binding protein 2 Proteins 0.000 claims description 6
- 108010090804 Streptavidin Proteins 0.000 claims description 6
- 101150016744 ermC gene Proteins 0.000 claims description 5
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 claims description 4
- 102100024746 Dihydrofolate reductase Human genes 0.000 claims description 4
- 108090000204 Dipeptidase 1 Proteins 0.000 claims description 4
- 101100206300 Escherichia coli tetC gene Proteins 0.000 claims description 4
- 101150047863 aacA-aphD gene Proteins 0.000 claims description 4
- 101150067314 aadA gene Proteins 0.000 claims description 4
- 108020001096 dihydrofolate reductase Proteins 0.000 claims description 4
- 101150071231 mecR1 gene Proteins 0.000 claims description 4
- 101150037181 vanB gene Proteins 0.000 claims description 4
- 102000003960 Ligases Human genes 0.000 claims description 3
- 108090000364 Ligases Proteins 0.000 claims description 3
- 101710099760 Tetracycline resistance protein Proteins 0.000 claims description 3
- 102000006635 beta-lactamase Human genes 0.000 claims description 3
- 101150031494 blaZ gene Proteins 0.000 claims description 3
- 101710116957 D-alanyl-D-alanine carboxypeptidase Proteins 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 229920002994 synthetic fiber Polymers 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims 1
- 108020004414 DNA Proteins 0.000 description 49
- 108091034117 Oligonucleotide Proteins 0.000 description 25
- 239000000872 buffer Substances 0.000 description 18
- 239000000047 product Substances 0.000 description 15
- 239000000203 mixture Substances 0.000 description 12
- 239000003242 anti bacterial agent Substances 0.000 description 11
- 229940088710 antibiotic agent Drugs 0.000 description 11
- 108091028043 Nucleic acid sequence Proteins 0.000 description 9
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 230000000295 complement effect Effects 0.000 description 6
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000011159 matrix material Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 108091000080 Phosphotransferase Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 102000020233 phosphotransferase Human genes 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- 238000010200 validation analysis Methods 0.000 description 3
- MYPYJXKWCTUITO-UHFFFAOYSA-N vancomycin Natural products O1C(C(=C2)Cl)=CC=C2C(O)C(C(NC(C2=CC(O)=CC(O)=C2C=2C(O)=CC=C3C=2)C(O)=O)=O)NC(=O)C3NC(=O)C2NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(CC(C)C)NC)C(O)C(C=C3Cl)=CC=C3OC3=CC2=CC1=C3OC1OC(CO)C(O)C(O)C1OC1CC(C)(N)C(O)C(C)O1 MYPYJXKWCTUITO-UHFFFAOYSA-N 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 241000194032 Enterococcus faecalis Species 0.000 description 2
- 229930182566 Gentamicin Natural products 0.000 description 2
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 241001147693 Staphylococcus sp. Species 0.000 description 2
- 108010059993 Vancomycin Proteins 0.000 description 2
- 125000003172 aldehyde group Chemical group 0.000 description 2
- 229960000723 ampicillin Drugs 0.000 description 2
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
- 102000023732 binding proteins Human genes 0.000 description 2
- 108091008324 binding proteins Proteins 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- -1 compound nucleic acid Chemical class 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 229960002518 gentamicin Drugs 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 101150025474 mecr gene Proteins 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229960003165 vancomycin Drugs 0.000 description 2
- MYPYJXKWCTUITO-LYRMYLQWSA-O vancomycin(1+) Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C2C=C3C=C1OC1=CC=C(C=C1Cl)[C@@H](O)[C@H](C(N[C@@H](CC(N)=O)C(=O)N[C@H]3C(=O)N[C@H]1C(=O)N[C@H](C(N[C@@H](C3=CC(O)=CC(O)=C3C=3C(O)=CC=C1C=3)C([O-])=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)O2)=O)NC(=O)[C@@H](CC(C)C)[NH2+]C)[C@H]1C[C@](C)([NH3+])[C@H](O)[C@H](C)O1 MYPYJXKWCTUITO-LYRMYLQWSA-O 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- ADIHZDIWDRJIOQ-JFGNBEQYSA-N (2s,5r,6r)-6-[[2-(3-chlorobut-2-enylsulfanyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid Chemical compound S1C(C)(C)[C@H](C(O)=O)N2C(=O)[C@@H](NC(=O)CSCC=C(Cl)C)[C@H]21 ADIHZDIWDRJIOQ-JFGNBEQYSA-N 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000186249 Corynebacterium sp. Species 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 102000055027 Protein Methyltransferases Human genes 0.000 description 1
- 108700040121 Protein Methyltransferases Proteins 0.000 description 1
- 239000002262 Schiff base Substances 0.000 description 1
- 150000004753 Schiff bases Chemical class 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 108010023191 Streptomycin 3''-adenylyltransferase Proteins 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000014670 detection of bacterium Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000002875 fluorescence polarization Methods 0.000 description 1
- 229960000308 fosfomycin Drugs 0.000 description 1
- YMDXZJFXQJVXBF-STHAYSLISA-N fosfomycin Chemical compound C[C@@H]1O[C@@H]1P(O)(O)=O YMDXZJFXQJVXBF-STHAYSLISA-N 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 229960003085 meticillin Drugs 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000002887 multiple sequence alignment Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 229940016590 sarkosyl Drugs 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- IEDVJHCEMCRBQM-UHFFFAOYSA-N trimethoprim Chemical compound COC1=C(OC)C(OC)=CC(CC=2C(=NC(N)=NC=2)N)=C1 IEDVJHCEMCRBQM-UHFFFAOYSA-N 0.000 description 1
- 229960001082 trimethoprim Drugs 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6832—Enhancement of hybridisation reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ATA337/2001 | 2001-03-02 | ||
| AT0033701A AT410444B (de) | 2001-03-02 | 2001-03-02 | Verfahren zur detektion von nukleinsäuremolekülen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2252427T3 true ES2252427T3 (es) | 2006-05-16 |
Family
ID=3672000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES02704467T Expired - Lifetime ES2252427T3 (es) | 2001-03-02 | 2002-03-01 | Procedimiento para la deteccion de moleculas de acido nucleico. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20050196756A1 (https=) |
| EP (1) | EP1366195B1 (https=) |
| JP (2) | JP2004520838A (https=) |
| KR (1) | KR100892184B1 (https=) |
| AT (1) | AT410444B (https=) |
| AU (1) | AU2002238274B2 (https=) |
| CA (1) | CA2439531A1 (https=) |
| CZ (1) | CZ20032665A3 (https=) |
| DE (1) | DE50204680D1 (https=) |
| DK (1) | DK1366195T3 (https=) |
| ES (1) | ES2252427T3 (https=) |
| HU (1) | HUP0303377A3 (https=) |
| NO (1) | NO20033884L (https=) |
| PL (1) | PL365022A1 (https=) |
| SK (1) | SK287793B6 (https=) |
| WO (1) | WO2002070736A2 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003144153A (ja) * | 2001-11-09 | 2003-05-20 | Gifu Univ | 遺伝子検出方法、遺伝子検出用プライマー、ｄｎａマイクロアレイ及び遺伝子検出用キット |
| KR100619189B1 (ko) * | 2004-10-08 | 2006-08-31 | 굿젠 주식회사 | 성교전파성질환 원인균 탐지용 프로브 및 이를 이용한성교전파성질환 원인균 유전자형 분석용 ｄｎａ 칩,분석키트 및 유전형 분석방법 |
| EP1674583A1 (en) * | 2004-12-23 | 2006-06-28 | Eppendorf Array Technologies SA | Method and kit for the detection of a large number of genes related to antibiotic resistance in microorganisms |
| US20070059714A1 (en) * | 2005-09-12 | 2007-03-15 | Birgit Strommenger | Detection of presence and antibiotic susceptibility of enterococci |
| AT504194B1 (de) * | 2006-09-07 | 2008-07-15 | Oesterr Rotes Kreuz | Bakteriennachweis |
| EP2270203A1 (en) | 2009-06-29 | 2011-01-05 | AIT Austrian Institute of Technology GmbH | Oligonucleotide hybridization method |
| WO2013176767A1 (en) | 2012-05-25 | 2013-11-28 | The University Of North Carolina At Chapel Hill | Microfluidic devices, solid supports for reagents and related methods |
| CA2894632A1 (en) * | 2012-11-15 | 2014-05-22 | Todd WALLACH | Pcr reaction mixtures and methods of using same |
| CN114272966B (zh) | 2015-07-22 | 2023-11-07 | 北卡罗来纳-查佩尔山大学 | 含有具有空间分离的珠保留和信号检测段的珠孔几何结构的流体装置和相关方法 |
| CN109789409A (zh) | 2016-10-07 | 2019-05-21 | 勃林格殷格翰维特梅迪卡有限公司 | 用于测试样品的方法和分析系统 |
| DK3523448T3 (da) * | 2016-10-07 | 2021-06-28 | Boehringer Ingelheim Vetmedica Gmbh | Fremgangsmåde og analysesystem til at teste en prøve |
| EP3523030B1 (en) | 2016-10-07 | 2021-05-05 | Boehringer Ingelheim Vetmedica GmbH | Analysis system and method for testing a sample |
| EP3794080B1 (en) | 2018-05-18 | 2024-04-10 | The University of North Carolina at Chapel Hill | Compositions, devices, and methods for improving a surface property of a substrate |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988003171A1 (en) * | 1986-10-30 | 1988-05-05 | Synergen Biologicals, Inc. | Human pancreatic secretory trypsin inhibitors produced by recombinant dna methods and processes for the production of same |
| CA1320162C (en) * | 1988-08-11 | 1993-07-13 | California Biotechnology Inc. | Method for stabilizing heterologous protein expression and vectors for use therein |
| US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| US5491225A (en) * | 1991-12-19 | 1996-02-13 | Hoffmann-La Roche Inc. | PCR primers for detection of legionella species and methods for controlling visual intensity in hybridization assays |
| US5837832A (en) * | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
| US6045996A (en) * | 1993-10-26 | 2000-04-04 | Affymetrix, Inc. | Hybridization assays on oligonucleotide arrays |
| US6063566A (en) * | 1994-05-13 | 2000-05-16 | The Scripps Research Institute | Catalytic RNA molecules |
| US6150093A (en) * | 1994-08-18 | 2000-11-21 | The Trustees Of Columbia University In The City Of New York | Unique associated Kaposi's sarcoma virus sequences and uses thereof |
| US6001564A (en) * | 1994-09-12 | 1999-12-14 | Infectio Diagnostic, Inc. | Species specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| US5702895A (en) * | 1995-01-19 | 1997-12-30 | Wakunaga Seiyaku Kabushiki Kaisha | Method and kit for detecting methicillin-resistant Staphylococcus aureus |
| US5994066A (en) * | 1995-09-11 | 1999-11-30 | Infectio Diagnostic, Inc. | Species-specific and universal DNA probes and amplification primers to rapidly detect and identify common bacterial pathogens and associated antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| US5612473A (en) * | 1996-01-16 | 1997-03-18 | Gull Laboratories | Methods, kits and solutions for preparing sample material for nucleic acid amplification |
| US5627054A (en) * | 1996-04-05 | 1997-05-06 | The United States Of America As Represented By The Secretary Of The Army | Competitor primer asymmetric polymerase chain reaction |
| GB9902970D0 (en) * | 1999-02-11 | 1999-03-31 | Zeneca Ltd | Novel matrix |
| GB9904804D0 (en) * | 1999-03-02 | 1999-04-28 | King S College London | Identification of bacteria |
| CN1117161C (zh) * | 1999-09-24 | 2003-08-06 | 东南大学 | 高密度基因芯片的制作方法 |
-
2001
- 2001-03-02 AT AT0033701A patent/AT410444B/de not_active IP Right Cessation
-
2002
- 2002-03-01 SK SK1083-2003A patent/SK287793B6/sk not_active IP Right Cessation
- 2002-03-01 WO PCT/AT2002/000060 patent/WO2002070736A2/de not_active Ceased
- 2002-03-01 HU HU0303377A patent/HUP0303377A3/hu unknown
- 2002-03-01 AU AU2002238274A patent/AU2002238274B2/en not_active Ceased
- 2002-03-01 CZ CZ20032665A patent/CZ20032665A3/cs unknown
- 2002-03-01 JP JP2002570758A patent/JP2004520838A/ja not_active Withdrawn
- 2002-03-01 US US10/469,713 patent/US20050196756A1/en not_active Abandoned
- 2002-03-01 KR KR1020037011418A patent/KR100892184B1/ko not_active Expired - Fee Related
- 2002-03-01 DE DE50204680T patent/DE50204680D1/de not_active Expired - Lifetime
- 2002-03-01 DK DK02704467T patent/DK1366195T3/da active
- 2002-03-01 EP EP02704467A patent/EP1366195B1/de not_active Expired - Lifetime
- 2002-03-01 PL PL02365022A patent/PL365022A1/xx not_active IP Right Cessation
- 2002-03-01 ES ES02704467T patent/ES2252427T3/es not_active Expired - Lifetime
- 2002-03-01 CA CA002439531A patent/CA2439531A1/en not_active Abandoned
-
2003
- 2003-09-02 NO NO20033884A patent/NO20033884L/no not_active Application Discontinuation
-
2010
- 2010-07-19 US US12/839,100 patent/US20100317535A1/en not_active Abandoned
- 2010-12-24 JP JP2010288416A patent/JP2011101652A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20100317535A1 (en) | 2010-12-16 |
| ATA3372001A (de) | 2002-09-15 |
| NO20033884L (no) | 2003-10-28 |
| JP2011101652A (ja) | 2011-05-26 |
| HUP0303377A2 (hu) | 2004-01-28 |
| SK10832003A3 (sk) | 2004-05-04 |
| CZ20032665A3 (cs) | 2005-02-16 |
| DK1366195T3 (da) | 2006-03-13 |
| JP2004520838A (ja) | 2004-07-15 |
| PL365022A1 (en) | 2004-12-27 |
| KR100892184B1 (ko) | 2009-04-07 |
| WO2002070736A2 (de) | 2002-09-12 |
| EP1366195B1 (de) | 2005-10-26 |
| WO2002070736A3 (de) | 2003-09-12 |
| EP1366195A2 (de) | 2003-12-03 |
| WO2002070736A8 (de) | 2003-01-23 |
| DE50204680D1 (de) | 2005-12-01 |
| AU2002238274B2 (en) | 2007-06-28 |
| HUP0303377A3 (en) | 2005-12-28 |
| AT410444B (de) | 2003-04-25 |
| NO20033884D0 (no) | 2003-09-02 |
| US20050196756A1 (en) | 2005-09-08 |
| SK287793B6 (sk) | 2011-10-04 |
| KR20030092009A (ko) | 2003-12-03 |
| CA2439531A1 (en) | 2002-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2374954T3 (es) | Variaciones genéticas asociadas con tumores. | |
| ES2773313T3 (es) | Sonda de ácido nucleico con un único marcador fluoróforo unido a una citosina interna para uso en amplificación isotérmica mediada por bucle | |
| ES2252427T3 (es) | Procedimiento para la deteccion de moleculas de acido nucleico. | |
| CN101801993A (zh) | 用于扩增和检测呼吸道病毒的核酸序列 | |
| KR20070011354A (ko) | 취약 ｘ염색체 증후군과 같은 ｓｔｒｐ의 검출 방법 | |
| CN110719957B (zh) | 用于核酸靶向富集的方法和试剂盒 | |
| JP2003527867A (ja) | ポリヌクレオチド配列改変のマイクロアレイベースの分析 | |
| CN101835905B (zh) | 靶rna的检测、定量方法和试剂盒 | |
| CN108374042A (zh) | 离子激流基因组测序 | |
| CN102741409A (zh) | 等位基因梯基因座 | |
| JP2006514826A (ja) | 核酸を分析するためのラボ・オン・チップシステム | |
| EP1160333A2 (en) | Oligonucleotides and method for detection of mecA gene of methicillin-resistant staphylococcus aureus | |
| KR20130029748A (ko) | ＩＬ28Ｂ(ｒｓ8099917)와 ＩＴＰＡ(ｒｓ1127354)의 변이를 검출하는 방법 | |
| CN110546274A (zh) | minor BCR-ABL1基因的检测方法 | |
| JP4972104B2 (ja) | 病原体の同定のためのオリゴヌクレオチドマイクロアレイ | |
| KR100468317B1 (ko) | 단일가닥 환형 분자를 탐침 ｄｎａ로 이용하는 ｄｎａ 칩 | |
| EP2453022A1 (en) | Method for detection or analysis of target sequence in genomic dna | |
| KR101338292B1 (ko) | Ａ형 간염 바이러스에 대한 역전사 중합효소 연쇄반응 효소면역 측정법 | |
| ES2308807T3 (es) | Procedimiento y kit para la identificacion de cepas de bacterias resistentes a antibioticos. | |
| JP6810559B2 (ja) | 環状型一本鎖核酸、およびその調製方法と使用方法 | |
| HK40063948A (en) | Systems and methods for clonal replication and amplification of nucleic acid molecules for genomic and therapeutic applications | |
| KR101677948B1 (ko) | 연쇄구균 감염증 원인세균인 스트렙토코카스 이니애의 판별 및 검출용 유전자 마커, 및 이를 이용한 원인세균의 판별 및 검출 방법 | |
| JP2004147503A (ja) | 核酸の高感度検出法 | |
| US20090075285A1 (en) | Primer kit | |
| CN108118094A (zh) | 骨肉瘤转移相关标志物ensg00000267886及其应用 |